- Home
- ONMD vs SYBX Comparison
ONMD vs SYBX Comparison
Compare ONMD & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- SYBX
- Stock Information
- Founded
- ONMD 2006
- SYBX N/A
- Country
- ONMD United States
- SYBX United States
- Employees
- ONMD N/A
- SYBX N/A
- Industry
- ONMD
- SYBX Biotechnology: Pharmaceutical Preparations
- Sector
- ONMD
- SYBX Health Care
- Exchange
- ONMD Nasdaq
- SYBX Nasdaq
- Market Cap
- ONMD 12.8M
- SYBX 13.6M
- IPO Year
- ONMD N/A
- SYBX N/A
- Fundamental
- Price
- ONMD $0.39
- SYBX $1.21
- Analyst Decision
- ONMD
- SYBX
- Analyst Count
- ONMD 0
- SYBX 0
- Target Price
- ONMD N/A
- SYBX N/A
- AVG Volume (30 Days)
- ONMD 151.9K
- SYBX 12.2K
- Earning Date
- ONMD 05-14-2025
- SYBX 06-17-2025
- Dividend Yield
- ONMD N/A
- SYBX N/A
- EPS Growth
- ONMD N/A
- SYBX N/A
- EPS
- ONMD N/A
- SYBX 0.21
- Revenue
- ONMD $532,000.00
- SYBX N/A
- Revenue This Year
- ONMD N/A
- SYBX N/A
- Revenue Next Year
- ONMD N/A
- SYBX N/A
- P/E Ratio
- ONMD N/A
- SYBX $5.82
- Revenue Growth
- ONMD N/A
- SYBX N/A
- 52 Week Low
- ONMD $0.30
- SYBX $0.90
- 52 Week High
- ONMD $2.16
- SYBX $1.88
- Technical
- Relative Strength Index (RSI)
- ONMD 44.41
- SYBX 58.34
- Support Level
- ONMD $0.35
- SYBX $1.00
- Resistance Level
- ONMD $0.39
- SYBX $1.27
- Average True Range (ATR)
- ONMD 0.04
- SYBX 0.04
- MACD
- ONMD -0.00
- SYBX 0.01
- Stochastic Oscillator
- ONMD 36.52
- SYBX 69.05
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.